OmniAb
OABI | NASDAQ
$4.89
-$0.02 (-0.41%)
At close: Nov 16, 2026, 4:00 PM ET
$4.89
$0.00 (0.00%)
After-hours:
Nov 16, 2026, 7:30 PM ET
-0.41%
(1D)No price chart data available for 1D timeframe.
Rating
49.2
Fundamentals Average
Market Sentiment Neutral
Moat Narrow
Sector Rank #301/1021 (Top 29%)
Key Statistics
Market Data
Market Cap $713.26M
1D Range
4.73 4.94
52W Range
1.36 5.30
Valuation (TTM)
PE -14.38
PB 2.86
EV/EBITDA -25.97
Valuation (NTM)
Forward PE N/A
Forward PEG 0.33
Price Target $4.00
Cash Flow
FCF Yield 0.3%
SBC Adj. FCF Yield -1.5%
SBC Impact -553.1%
Margins
Gross Margin 63.6%
Operating Margin -115.8%
FCF Margin 5.9%
Growth (CAGR)
Revenue 3Y | 5Y -14.7% |
4.8%
Dil EPS 3Y | 5Y 27.3% |
-8.9%
FCF 3Y | 5Y 92.6% |
9.2%
Returns
ROA -14.9%
ROE -16.7%
ROIC -16.4%
Financial Health
Net Cash
$46.07M
Current Ratio 4.21
Interest Coverage 0.00
Dividends
Div Yield N/A
Payout Ratio N/A
FCF Payout Ratio N/A
Loading financial charts...
Profile
OmniAb, Inc. is an American biotechnology firm focused on pioneering therapeutic antibody discovery. The company provides a sophisticated platform that allows its industry partners to access a broad s...
Sector Healthcare
Industry Biotechnology
Employees 89
IPO Date Sep 30, 2021
Website www.omniab.com
Fiscal Year January - December
Latest News
No news articles available yet.
Earnings
Latest Earnings
Oct 30, 2026
EPS
-$0.12
Beat +5.62%
YoY:
+14.29% REV
$3.99M
Beat +14.34%
YoY:
+78.34%Next Earnings
Mar 3, 2027
EPS Est
Pro
Rev Est
Pro
Analyst Summary
# of Analysts
3
Consensus
Buy
Price Target
$4.00
Downside
-18.20%
Buy (3)
Hold (0)
Sell (0)
Add to Watchlist
Select watchlists to add or remove OABI